WWW.JNEUROSCI.ORG
-
The Journal of Neuroscience
 QUICK SEARCH:   [advanced]


     
-


HOME
  |  
SEARCH  |   ARCHIVE  |   SUBSCRIBE  |   CONTACT  |   HELP

The Journal of Neuroscience, October 10, 2007, 27(41):11056-11064; doi:10.1523/JNEUROSCI.1941-07.2007

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit an eLetter
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Parker, J. A.
Right arrow Articles by Néri, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Parker, J. A.
Right arrow Articles by Néri, C.

 Previous Article  |  Next Article 

Neurobiology of Disease
Huntingtin-Interacting Protein 1 Influences Worm and Mouse Presynaptic Function and Protects Caenorhabditis elegans Neurons against Mutant Polyglutamine Toxicity

J. Alex Parker,1,2 Martina Metzler,3 John Georgiou,4 Marilyne Mage,1,2 John C. Roder,4,5 Ann M. Rose,6 Michael R. Hayden,3 and Christian Néri1,2

1Inserm, Unit 857 "Neuronal Cell Biology and Pathology," and 2University of Paris René Descartes, Equipe d'Accueil 4059, Centre Paul Broca, 75014 Paris, France, 3Centre for Molecular Medicine and Therapeutics, Child and Family Research Institute, Department of Medical Genetics, University of British Columbia, Vancouver, British Columbia, Canada V5Z 4H4, 4Samuel Lunenfeld Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada M5G 1X5, 5Department of Physiology, University of Toronto, Toronto, Ontario, Canada M5S 1A8, and 6Department of Medical Genetics, University of British Columbia, Vancouver, British Columbia, Canada V6T 1Z3

Correspondence should be addressed to either Christian Néri or J. Alex Parker, Institut National de la Santé et de la Recherche Médicale, Unit 857 "Neuronal Cell Biology and Pathology," Centre Paul Broca, 75014 Paris, France. Email: neri{at}broca.inserm.fr or Email: parker{at}broca.inserm.fr

Huntingtin-interacting protein 1 (HIP1) was identified through its interaction with htt (huntingtin), the Huntington's disease (HD) protein. HIP1 is an endocytic protein that influences transport and function of AMPA and NMDA receptors in the brain. However, little is known about its contribution to neuronal dysfunction in HD.

We report that the Caenorhabditis elegans HIP1 homolog hipr-1 modulates presynaptic activity and the abundance of synaptobrevin, a protein involved in synaptic vesicle fusion. Presynaptic function was also altered in hippocampal brain slices of HIP1–/– mice demonstrating delayed recovery from synaptic depression and a reduction in paired-pulse facilitation, a form of presynaptic plasticity. Interestingly, neuronal dysfunction in transgenic nematodes expressing mutant N-terminal huntingtin was specifically enhanced by hipr-1 loss of function. A similar effect was observed with several other mutant proteins that are expressed at the synapse and involved in endocytosis, such as unc-11/AP180, unc-26/synaptojanin, and unc-57/endophilin.

Thus, HIP1 is involved in presynaptic nerve terminal activity and modulation of mutant polyglutamine-induced neuronal dysfunction. Moreover, synaptic proteins involved in endocytosis may protect neurons against amino acid homopolymer expansion.

Key words: HIP1; synapse; synaptic plasticity; polyglutamine; Huntington's disease; neurodegeneration


Received April 30, 2007; revised July 30, 2007; accepted Aug. 20, 2007.

Correspondence should be addressed to either Christian Néri or J. Alex Parker, Institut National de la Santé et de la Recherche Médicale, Unit 857 "Neuronal Cell Biology and Pathology," Centre Paul Broca, 75014 Paris, France. Email: neri{at}broca.inserm.fr or Email: parker{at}broca.inserm.fr




This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
J. L. Marsh, T. Lukacsovich, and L. M. Thompson
Animal Models of Polyglutamine Diseases and Therapeutic Approaches
J. Biol. Chem., March 20, 2009; 284(12): 7431 - 7435.
[Abstract] [Full Text] [PDF]


Home page
Hum Mol GenetHome page
T. Kuwahara, A. Koyama, S. Koyama, S. Yoshina, C.-H. Ren, T. Kato, S. Mitani, and T. Iwatsubo
A systematic RNAi screen reveals involvement of endocytic pathway in neuronal dysfunction in {alpha}-synuclein transgenic C. elegans
Hum. Mol. Genet., October 1, 2008; 17(19): 2997 - 3009.
[Abstract] [Full Text] [PDF]



-

Home  |   Search  |   Archive  |   Subscribe  |   Contact  |   Help

-
Copyright 2009 by Society for Neuroscience ONLINE ISSN: 1529-2401
-